ePrivacy and GPDR Cookie Consent by TermsFeed Generator

ALEXAN

50MG/ML INF CNC SOL 1X20ML

Announcement of launch, break or close-out of marketing of a medicinal product
Type of announcement Effective date Alternate medicines ? Reason for interruption/cessation of marketing Estimated renewal date
Resumption of marketing 12.09.2019
Interruption of marketing 11.03.2019 0195769, 0195770
Lék obtížně nahraditelný LP Cytarabine Accord 100 mg/ml - LP v jiné síle a lékové formě (nutná úprava dávkovaní dle potřeby pacienta).Cytarabine Accord 100 mg/ml se nesmí podávat intratekálně.
Capacity/distribution reasons 24. týden
Resumption of marketing 22.08.2018
Interruption of marketing 01.08.2018 0100328
Resumption of marketing 01.03.2017
Interruption of marketing 04.01.2017 0100328
Placing on the market 13.03.2014
Cessation of marketing 21.07.2011 0100328
Resumption of marketing 08.07.2011
Interruption of marketing 22.06.2011 0100328

All reports are available in the Overview.

Back to list